Literature DB >> 10469392

Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors.

K Tazawa1, Y Kurihara, S Kamoshida, K Tsukada, Y Tsutsumi.   

Abstract

Immunoreactivity of prostate-specific antigen (PSA), a kallikrein-like enzyme present in the seminal plasma, was demonstrated by indirect immunoperoxidase staining using a PSA antiserum in the apical cytoplasm along the luminal border of small-sized duct epithelial cells of the major salivary (parotid and submandibular) gland of both sexes (56/56, 100%). No PSA-like immunoreactivity was seen in large-sized duct epithelial cells and acinar cells. Minor salivary gland ducts were negative. When inflammatory and atrophic changes were observed, ductal expression of PSA-like immunoreactivity was decreased (12/37, 32%) and the site of intracellular localization often became diffusely cytoplasmic. The immunoreactivity was absorbed by human seminal plasma. Immunoreactivities of prostatic acid phosphatase and sex hormone receptors were undetectable in the salivary gland. Twenty-nine (34%) of 86 salivary gland tumors with ductal differentiation were immunoreactive for PSA mainly in the cytoplasm. A PSA monoclonal antibody ER-PR8 detected immunoreactivity in the prostate but not in the salivary glands or their tumors. Prostate-specific antigen-like immunoreactivity in small-sized (intercalated) duct epithelial cells of the major salivary gland and their tumors may be due to cross-reactivity of the antiserum with kallikrein-like substances.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469392     DOI: 10.1046/j.1440-1827.1999.00900.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Nothing to Spit At.

Authors:  Nafiseh Hashemi; Shahreen Billah; Christian P Conderman; Ibrahim Alava; Emilio P Supsupin; Patricia Chevez-Barrios; Ore-Ofe O Adesina
Journal:  J Neuroophthalmol       Date:  2017-12       Impact factor: 3.042

Review 2.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

3.  Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities.

Authors:  Kailash C Chadha; Bindukumar B Nair; Srikant Chakravarthi; Rita Zhou; Alejandro Godoy; James L Mohler; Ravikumar Aalinkeel; Stanley A Schwartz; Gary J Smith
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

4.  Well-differentiated acinic cell carcinoma with lymphoid stroma associated with osteoclast-like giant cells of the parotid gland in children: a case report and literature review.

Authors:  Zhengjin Liu; Chao Pan; Ping Yin; Hongfeng Liao
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Novel case of androgen receptor-positive cancer of unknown primary without serum prostate-specific antigen elevation that became progression free in the long term after primary combined androgen blockade.

Authors:  Nayuka Matsuyama; Taku Naiki; Aya Naiki-Ito; Ryosuke Chaya; Tatsuya Kawai; Toshiki Etani; Takashi Nagai; Hiroyuki Kato; Yasue Kubota; Takahiro Yasui
Journal:  IJU Case Rep       Date:  2020-11-30

6.  Oral cavity metastasis: An unusual presentation of carcinoma prostate.

Authors:  Dileep Damodaran; N Kathiresan; B Satheesan
Journal:  Indian J Urol       Date:  2008-01

Review 7.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

8.  A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Authors:  Hiromichi Iwamura; Shingo Hatakeyama; Yoshimi Tanaka; Toshikazu Tanaka; Noriko Tokui; Hayato Yamamoto; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Kazuaki Yoshikawa; Chikara Ohyama
Journal:  BMC Res Notes       Date:  2014-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.